Lowered VAT Rate Transfer to the Consumer Prices: Selected Medicaments Case Study

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60460709%3A41110%2F19%3A79334" target="_blank" >RIV/60460709:41110/19:79334 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

čeština

Original language name

Lowered VAT Rate Transfer to the Consumer Prices: Selected Medicaments Case Study

Original language description

The contribution focuses on changes in the tax burden on consumers following the introduction of a second reduced rate of value added tax on selected products. The shift in tax burden was assessed on a sample of specific pharmacy products that had been included in the second reduced VAT rate since 1st January 2015. Based on the pharmacy chain recommendations that provided the necessary data, the products were selected as a typical assortment sample, including contraception, high blood pressure medication, vaccine, antibiotics, and baby food. The provided data included mainly sales prices for final consumer for selected products in the months of 2014 and 2015. Data on sales prices were adjusted for inflation. The results show that the impact of the inclusion of selected products in the second reduced VAT rate on the final consumer price was positive. Reducing the VAT rate by including the price change set by the vendor and including inflation reduced the tax burden on the final consumer for all the pr

Czech name

Lowered VAT Rate Transfer to the Consumer Prices: Selected Medicaments Case Study

Czech description

The contribution focuses on changes in the tax burden on consumers following the introduction of a second reduced rate of value added tax on selected products. The shift in tax burden was assessed on a sample of specific pharmacy products that had been included in the second reduced VAT rate since 1st January 2015. Based on the pharmacy chain recommendations that provided the necessary data, the products were selected as a typical assortment sample, including contraception, high blood pressure medication, vaccine, antibiotics, and baby food. The provided data included mainly sales prices for final consumer for selected products in the months of 2014 and 2015. Data on sales prices were adjusted for inflation. The results show that the impact of the inclusion of selected products in the second reduced VAT rate on the final consumer price was positive. Reducing the VAT rate by including the price change set by the vendor and including inflation reduced the tax burden on the final consumer for all the pr

Type

D - Article in proceedings

CEP classification

—

OECD FORD branch

50202 - Applied Economics, Econometrics

Project

—

Continuities

S - Specificky vyzkum na vysokych skolach

Publication year

2019

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Article name in the collection

European Financial Systems 2019: Proceedings of the 16th International Scientific Conference

ISBN

978-80-210-9338-6

ISSN

—

e-ISSN

—

Number of pages

8

Pages from-to

345-352

Publisher name

MASARYKOVA UNIV, ZEROTINOVO NAM 617-9, BRNO 601 77, CZECH REPUBLIC

Place of publication

Brno, Czech Rep.

Event location

Brno, Czech Republic

Event date

Jun 24, 2019

Type of event by nationality

WRD - Celosvětová akce

UT code for WoS article

000503222600040